National brain tumour research funding needs to increase to £30-35 million a year
Research sheds new light on how brain stem cells are activated
Our brains are notoriously bad at regenerating cells that have been lost through injury or disease: yet the same neural stem cells that struggle to repair some types of damage can mutate to drive brain tumour growth and hence cause damage as well. While therapies using neural stem cells (NSCs) hold the promise of replacing lost cells, scientists need to better understand how NSCs behave in the brain in order to develop effective treatments for both injury and brain tumours.
Now research led by our Brain Tumour Research Centre at the University of Plymouth helps to shed new light on the mechanisms used by NSCs to ‘wake up’ – going from their usual dormant state to one of action – which could hold the key for both instigating and controlling their behaviour.
The new study, conducted using Drosophila fruit flies, shows that molecules that form a complex called STRIPAK are essential to promote reactivation in NSCs. STRIPAK (Striatin-interacting phosphatase and kinase) is found in organisms from fungi to humans, and the team uncovered it when comparing the genetic messages of dormant and reactivated NSCs in live fly brains.
The researchers then discovered that STRIPAK components act as a switch to turn off dormancy (or quiescence) and turn on reactivation.
Lead author Dr Claudia Barros (pictured), from the Institute of Translational and Stratified Medicine at the University of Plymouth, acknowledges there is still a long way to go until such findings can be translated into human treatments. But she explains the significance of the new work:
“So little is currently known about how neural stem cells coordinate cues to become active and direct the production of more brain cells,” she said. “These stem cells last throughout life mainly in a dormant state, so learning how they work is critical to our understanding of cell regeneration.
“This study reveals that STRIPAK molecules are essential to enable reactivation in NSCs, and we are very pleased with the outcomes. But we are only at the beginning. We are working to expand our findings and bring us closer to the day when human neural stem cells can be controlled and efficiently used to facilitate brain damage repair, or even prevent brain cancer growth that is fuelled by stem-like cells.”
- Viruses that could target glioblastoma brain tumours
- Breakthrough in meningioma profiling provides hope for new treatments